Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product

An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a

Read more

No Benefit Seen With Everolimus in Early Breast Cancer

Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy

Read more

Chemo-Induced Neuropathy Linked With Low Hemoglobin, BMI, Age

NEW YORK (Reuters Health) – Older patients with low hemoglobin and higher body mass index – particularly women – were

Read more

Bladder Cancer Indication Withdrawn for Durvalumab

After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be

Read more

Maxolon

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MAXOLON® Metoclopramide hydrochloride Consumer Medicine Information What

Read more